AKT1 and prostate carcinoma: In the next series of experiments, we have determined mTORC2 activity in mTOR (Figure 8A) and Rictor immunoprecipitates (Figure 8B) by quantifying the phosphorylation of Akt1 at S473 in prostate cancer cells stimulated with α2M*.